Spark Biomedical
DALLAS, TX · Health Care · 34 employees
Spark Biomedical, Inc. is a leading U.S.-based medical device developer, committed to unlocking the potential of bioelectronic medicine and bringing to market novel wearable neurostimulation treatment options in behavioral health, women's health, hemostasis, pediatrics, and chronic pain. Spark leverages its neuroscience and engineering expertise to empower healthcare providers and researchers with
Funding history
- Series series a — $15.0M — Apr 2025
- Funding Round — $16.2M — May 2023
Recent signals
- May 04, 2026: Spark Biomedical Appoints Anja Krammer as Chief Executive Officer
- Apr 30, 2025: Raised $15.0M in Series series a
- Feb 20, 2025: Spark Biomedical Partners With Air Force To Launch Trial Testing tAN® for Motion Sickness and Spatial Disorientation
- May 12, 2023: Raised $16.2M
See plans & pricing → Track Spark Biomedical’s funding, hiring, and signals — with verified contacts — on Fundz.